Jos Even

5.8k total citations · 2 hit papers
73 papers, 4.5k citations indexed

About

Jos Even is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Jos Even has authored 73 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Immunology, 19 papers in Molecular Biology and 19 papers in Oncology. Recurrent topics in Jos Even's work include Immunotherapy and Immune Responses (23 papers), T-cell and B-cell Immunology (22 papers) and Monoclonal and Polyclonal Antibodies Research (19 papers). Jos Even is often cited by papers focused on Immunotherapy and Immune Responses (23 papers), T-cell and B-cell Immunology (22 papers) and Monoclonal and Polyclonal Antibodies Research (19 papers). Jos Even collaborates with scholars based in France, Luxembourg and United States. Jos Even's co-authors include Christophe Pannetier, Philippe Kourilsky, Philippe Kourilsky, Jean Kanellopoulos, T. Petteri Arstila, Armanda Casrouge, Véronique Baron, Mark E. Dudley, Thomas E. Shelton and Steven A. Rosenberg and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Jos Even

73 papers receiving 4.4k citations

Hit Papers

A Direct Estimate of the Human αβ T Cell Receptor Diversity 1999 2026 2008 2017 1999 2003 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jos Even France 32 3.2k 1.3k 903 529 518 73 4.5k
Christophe Pannetier France 33 3.9k 1.2× 967 0.7× 960 1.1× 246 0.5× 528 1.0× 55 5.1k
Gary S. Gray United States 27 3.2k 1.0× 1.0k 0.8× 1.2k 1.3× 582 1.1× 292 0.6× 36 5.4k
Béatrice Vanbervliet France 34 7.1k 2.2× 1.6k 1.3× 1.4k 1.5× 469 0.9× 561 1.1× 47 8.4k
Sem Saeland France 40 6.8k 2.1× 1.2k 0.9× 1.4k 1.5× 316 0.6× 632 1.2× 74 8.7k
G S Gray United States 29 3.6k 1.1× 764 0.6× 865 1.0× 367 0.7× 279 0.5× 37 4.9k
Bjarne Bogen Norway 42 4.7k 1.5× 1.8k 1.3× 1.8k 2.0× 1.1k 2.0× 613 1.2× 182 6.5k
Gayle C. Bosma United States 21 2.3k 0.7× 768 0.6× 1.3k 1.5× 518 1.0× 495 1.0× 42 4.2k
Jennifer L. Cannons United States 31 4.9k 1.5× 1.2k 0.9× 760 0.8× 158 0.3× 447 0.9× 45 5.9k
Helen Tighe United States 25 3.0k 0.9× 371 0.3× 1.2k 1.3× 557 1.1× 636 1.2× 43 4.8k
Ellen I. H. van der Voort Netherlands 28 4.7k 1.5× 1.5k 1.1× 967 1.1× 449 0.8× 371 0.7× 37 5.4k

Countries citing papers authored by Jos Even

Since Specialization
Citations

This map shows the geographic impact of Jos Even's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jos Even with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jos Even more than expected).

Fields of papers citing papers by Jos Even

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jos Even. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jos Even. The network helps show where Jos Even may publish in the future.

Co-authorship network of co-authors of Jos Even

This figure shows the co-authorship network connecting the top 25 collaborators of Jos Even. A scholar is included among the top collaborators of Jos Even based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jos Even. Jos Even is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Letellier, Elisabeth, Martine Schmitz, Kamran Baig, et al.. (2014). Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer. British Journal of Cancer. 111(4). 726–735. 57 indexed citations
3.
Mossong, Joël, et al.. (2009). Mumps outbreak among the military in Luxembourg in 2008: epidemiology and evaluation of control measures. Eurosurveillance. 14(7). 16 indexed citations
4.
Even, Jos, et al.. (2008). Characteristics of a French African Caribbean Epidemiological Psychiatric Sample with a History of Suicide Attempt. Suicide and Life-Threatening Behavior. 38(6). 720–727. 4 indexed citations
5.
Mariani, Sara, Marta Coscia, Jos Even, et al.. (2001). Severe and long‐lasting disruption of T‐cell receptor diversity in human myeloma after high‐dose chemotherapy and autologous peripheral blood progenitor cell infusion. British Journal of Haematology. 113(4). 1051–1059. 42 indexed citations
6.
Faure, Florence, Jos Even, & Philippe Kourilsky. (1998). Tumor-Specific Immune Response: Current In Vitro Analyses May Not Reflect the In Vivo Immune Status. Critical Reviews in Immunology. 18(1-2). 77–86. 38 indexed citations
7.
Prisco, Antonella, Riccardo Bonfanti, Giuseppe Mazzarella, et al.. (1997). Identical T-Cell Receptor β Chain Rearrangements Are Present in T Cells Infiltrating the Jejunal Mucosa of Untreated Celiac Patients. Human Immunology. 55(1). 22–33. 19 indexed citations
8.
Puisieux, Isabelle, Christine Bain, Yacine Merrouche, et al.. (1996). Restriction of the T-cell repertoire in tumor-infiltrating lymphocytes from nine patients with renal-cell carcinoma relevance of the CDR3 length analysis for the identification ofin situ clonal T-cell expansions. International Journal of Cancer. 66(2). 201–208. 32 indexed citations
9.
David-Ameline, Jacques, Apiradee Lim, François Davodeau, et al.. (1996). Selection of T cells reactive against autologous B lymphoblastoid cells during chronic rheumatoid arthritis. The Journal of Immunology. 157(10). 4697–4706. 44 indexed citations
10.
11.
Bour, H, et al.. (1994). Oligoclonal T cell response in psoriatic cutaneous lesions. Journal of Investigative Dermatology. 103(3). 453. 1 indexed citations
12.
Puisieux, Isabelle, Jos Even, Christophe Pannetier, et al.. (1994). Oligoclonality of tumor-infiltrating lymphocytes from human melanomas.. The Journal of Immunology. 153(6). 2807–2818. 213 indexed citations
13.
Dietrich, PY, Anne Caignard, Apiradee Lim, et al.. (1994). In vivo T-cell clonal amplification at time of acute graft-versus-host disease. Blood. 84(8). 2815–2820. 11 indexed citations
14.
Milstein, César, Jos Even, John M. Jarvis, África González‐Fernández, & Ermanno Gherardi. (1992). Non‐random features of the repertoire expressed by the members of one Vx gene family and of the V‐J recombination. European Journal of Immunology. 22(6). 1627–1634. 26 indexed citations
15.
Hogarth, P. Mark, Ewa Witort, Mark D. Hulett, et al.. (1991). Structure of the mouse beta Fc gamma receptor II gene. The Journal of Immunology. 146(1). 369–376. 37 indexed citations
16.
Hogarth, P. Mark, et al.. (1990). Molecular and functional studies of recombinant soluble Fcγ receptors. Molecular Immunology. 27(12). 1201–1207. 15 indexed citations
17.
Bonnerot, Christian, Sebastián Amigorena, Wolf H. Fridman, Jos Even, & Marc Daëron. (1990). Unmethylation of specific sites in the 5' region is critical for the expression of murine alpha FcgammaR gene.. The Journal of Immunology. 144(1). 323–328. 14 indexed citations
18.
Daëron, Marc, Catherine Sautès‐Fridman, Christian Bonnerot, et al.. (1989). Murine Type II Fcγ Receptors and IgG-Binding Factors. Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy. 47. 21–40. 23 indexed citations
19.
Varin‐Blank, Nadine, Catherine Sautès‐Fridman, Annie Galinha, et al.. (1989). Recombinant soluble receptors for the Fcγ portion inhibit antibody production in vitro. European Journal of Immunology. 19(12). 2263–2268. 42 indexed citations
20.
Kaartinen, Matti, et al.. (1988). V genes of the primary antibody response of C57BL110 mice to the hapten phenyloxazolone. European Journal of Immunology. 18(7). 1095–1100. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026